Climate Change Data

Sedana Medical AB (publ)

Climate Impact & Sustainability Data (2022, 2023, 2024)

Reporting Period: 2022

Environmental Metrics

ESG Focus Areas

  • Sustainability
  • Human Rights
  • Responsible Procurement
  • Environmental Impact

Environmental Achievements

  • Continued efforts to minimize plastic use in packaging
  • Increased reflection efficiency of Sedaconda ACD
  • Increased capture efficiency and potential recycling of anesthetic gas
  • Minimizing air freight and using sea freight for at least 90% of incoming freight volumes

Social Achievements

  • Developed an anti-corruption policy and updated the code of conduct
  • Introduced a mentorship program for new managers
  • Established a legal function and appointed a chief legal officer
  • Developed new policies and procedures (anti-corruption, corporate governance, HR)
  • Launched 'I Suggest' tool for employee suggestions
  • Introduced 'Board Member for a Day' initiative

Governance Achievements

  • Updated Code of Conduct
  • Developed an anti-corruption policy
  • Established a legal function and appointed a chief legal officer
  • Developed a whistleblower policy and implemented a whistleblower system

Climate Goals & Targets

Long-term Goals:
  • Make inhaled sedation a global standard therapy for mechanically ventilated patients in intensive care
Medium-term Goals:
  • Achieve sales in excess of SEK 500 million in Europe by 2025
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Reduced sales due to fewer ICU patients and hospital staff shortages post-Covid-19 pandemic
  • War in Ukraine impacting supply of AMG-06 gas monitors
  • Risks related to regulatory environment for medical devices and pharmaceutical products
  • Risks related to product classification system or market access process
  • Risks related to implementation and outcomes of clinical studies
  • Risks related to competition
  • Risks related to third-party agreements
  • Risks related to market acceptance
  • Risks related to macroeconomic factors
  • Dependence on sales and development of a small number of devices
  • Risks related to key individuals and qualified personnel
  • Risks related to intellectual property rights
  • Risks related to fluctuating foreign-exchange rates
  • Risks related to current and additional financing
  • Risks related to tax demands and changes in tax regulations
  • Risks related to accumulated tax losses
Mitigation Strategies
  • Halted purchases of AMG-06 gas monitors from Russia and sought alternative suppliers
  • Developed an anti-corruption policy and updated the code of conduct
  • Established a legal function and appointed a chief legal officer
  • Developed new policies and procedures (anti-corruption, corporate governance, HR)
  • Implemented a whistleblower system
  • Focusing on implementing main priorities: sales growth, cost-effectiveness, and completion of US studies
  • Securing medical evidence demonstrating inhaled sedation benefits
  • Continuous dialogue with suppliers to ensure compliance with Code of Conduct
  • Proactive cooperation with key stakeholders to minimize environmental impact

Supply Chain Management

Supplier Audits: Ongoing dialogue and regular review of suppliers

Responsible Procurement
  • Inclusion of clauses in supplier agreements requiring compliance with Code of Conduct

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Global Compact

Certifications: ISO 13485, MDR 2017/745, MDSAP

Sustainable Products & Innovation

  • Sedaconda ACD (designed for efficient anesthetic use and reduced environmental impact)

Reporting Period: 2023

Environmental Metrics

ESG Focus Areas

  • Sustainability

Climate Goals & Targets

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2024

Environmental Metrics

ESG Focus Areas

  • Sustainability

Climate Goals & Targets

Supply Chain Management

Climate-Related Risks & Opportunities